Surmodics (SRDX)
(Delayed Data from NSDQ)
$35.41 USD
-0.22 (-0.62%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $35.43 +0.02 (0.06%) 7:58 PM ET
5-Strong Sell of 5 5
F Value A Growth A Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Surmodics, Inc. has a market cap of $509.48M, which represents its share price of $35.63 multiplied by its outstanding shares number of 14.30M. As a small-cap company, SRDX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SRDX 35.41 -0.22(-0.62%)
Will SRDX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SRDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SRDX
Evolus, Inc. (EOLS) Reports Q2 Loss, Lags Revenue Estimates
QuidelOrtho (QDEL) Down 18% Since Last Earnings Report: Can It Rebound?
SRDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is SurModics (SRDX) Up 6% Since Last Earnings Report?
Are Options Traders Betting on a Big Move in Surmodics Stock?
SRDX Stock Down Following Q2 Earnings Miss, Gross Margin Contracts
Other News for SRDX
Surmodics (SRDX) Stock Drops Amid FTC Deadline Extension Request
Surmodics falls as parties, FTC ask for extension of briefing schedule
Noteworthy Monday Option Activity: SRDX, CR, SPOT
Surmodics (SRDX) Shares Climb 12% Amid FTC Pre-Trial Hearing
Surmodics jumps amid pre-trial hearing in FTC's suit to block sale to GTCR